BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19557647)

  • 1. Clofarabine in relapsed lymphoma: what is the optimal dose?
    Nabhan C
    Leuk Lymphoma; 2009 Jul; 50(7):1230-1; author reply 1232-4. PubMed ID: 19557647
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.
    Abramson JS; Takvorian RW; Fisher DC; Feng Y; Jacobsen ED; Brown JR; Barnes JA; Neuberg DS; Hochberg EP
    Leuk Lymphoma; 2013 Sep; 54(9):1915-20. PubMed ID: 23289359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.
    Choi J; Foss F
    Yale J Biol Med; 2006 Dec; 79(3-4):169-72. PubMed ID: 17940627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
    Racil Z; Toskova M; Dvorakova D; Jeziskova I; Razga F; Buresova L; Timilsina S; Mayer J
    Am J Hematol; 2012 Feb; 87(2):211-3. PubMed ID: 22052688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia].
    Suo P; Zhang LP; Wu J; Lu AD; Wang B; Zuo YX; Cheng YF; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):444-7. PubMed ID: 23791059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
    O'Connor D; Sibson K; Caswell M; Connor P; Cummins M; Mitchell C; Motwani J; Taj M; Vora A; Wynn R; Kearns PR
    Br J Haematol; 2011 Aug; 154(4):482-5. PubMed ID: 21689087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
    McGregor BA; Brown AW; Osswald MB; Savona MR
    Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofarabine: emerging role in leukemias.
    Sampat K; Kantarjian H; Borthakur G
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia.
    Steinherz PG; Meyers PA; Steinherz LJ; Jeha S
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):656-8. PubMed ID: 17805046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.
    Douer D; Watkins K; Levine AM; Weiss JM; Marshall LC; Craig AR
    Leuk Lymphoma; 2003 Dec; 44(12):2135-6. PubMed ID: 14959859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine for the treatment of adult acute myeloid leukemia.
    Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H
    Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.
    Burnett AK; Russell NH; Hunter AE; Milligan D; Knapper S; Wheatley K; Yin J; McMullin MF; Ali S; Bowen D; Hills RK;
    Blood; 2013 Aug; 122(8):1384-94. PubMed ID: 23838349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine: a size that fits all, may not fit all.
    Vij R
    Leuk Lymphoma; 2009 Mar; 50(3):309-10. PubMed ID: 19347718
    [No Abstract]   [Full Text] [Related]  

  • 15. Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children.
    McDonald LR; McCarthy CH
    Clin J Oncol Nurs; 2006 Dec; 10(6):809-15. PubMed ID: 17193947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
    Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
    Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
    Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
    Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
    [No Abstract]   [Full Text] [Related]  

  • 19. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
    Dressel A; Kwari M; McGreal AM
    Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients.
    Nabhan C; Davis N; Bitran JD; Galvez A; Fried W; Tolzien K; Foss S; Dewey WM; Venugopal P
    Cancer; 2011 Apr; 117(7):1490-7. PubMed ID: 21425150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.